Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: An observational study

Journal of Heart and Lung Transplantation

Volumn 31, Issue 2, 2012, Pages 150-158

  Kemp, Kristina ^a,b,c   Savale, Laurent ^a,b,c   O'Callaghan, Dermot S ^a,b,c   Jaís, Xavier ^a,b,c   Montani, David ^a,b,c   Humbert, Marc ^a,b,c   Simonneau, Gérald ^a,b,c   Sitbon, Olivier ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Universite Paris Sud   (France)

Author keywords

combination therapy; endothelin receptor antagonist; hypertension; observational study; prostacyclin; pulmonary; pulmonary arterial hypertension

Indexed keywords

BOSENTAN; PROSTACYCLIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EXERCISE; FOLLOW UP; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MONOTHERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR RESISTANCE; WALKING;

ADULT; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; DRUG THERAPY, COMBINATION; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84856469571     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.11.002     Document Type: Article

References (29)

1. M. Humbert, O. Sitbon, G. Simonneau Treatment of pulmonary arterial hypertension N Engl J Med 351 2004 1425 1436
2. N. Gali, M.M. Hoeper, M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 2009 1219 1263
3. N. Gali, M.M. Hoeper, M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
4. V.V. McLaughlin, K.W. Presberg, R.L. Doyle Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 2004 78S 92S (Pubitemid 38932344)
5. G.E. D'Alonzo, R.J. Barst, S.M. Ayres Survival in patients with primary pulmonary hypertension Results from a national prospective study Ann Intern Med 115 1991 343 349
6. D.B. Badesch, S.H. Abman, G. Simonneau Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines Chest 131 2007 1917 1928 (Pubitemid 46981654)
7. R.J. Barst, J.S. Gibbs, H.A. Ghofrani Updated evidence-based treatment algorithm in pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S78 S84
8. M.M. Hoeper, A.T. Dinh-Xuan Combination therapy for pulmonary arterial hypertension: still more questions than answers Eur Respir J 24 2004 339 340 (Pubitemid 39232249)
9. M.M. Hoeper, I. Markevych, E. Spiekerkoetter Goal-oriented treatment and combination therapy for pulmonary arterial hypertension Eur Respir J 26 2005 858 863 (Pubitemid 41632043)
10. M. Humbert, R.J. Barst, I.M. Robbins Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 Eur Respir J 24 2004 353 359 (Pubitemid 39232254)
11. D. O'Callaghan, S.P. Gaine Combination therapy and new types of agents for pulmonary arterial hypertension Clin Chest Med 28 2007 169 185 (Pubitemid 46330547)
12. R.L. Benza, M.H. Park, A. Keogh Management of pulmonary arterial hypertension with a focus on combination therapies J Heart Lung Transplant 26 2007 437 446 (Pubitemid 46602007)
13. D.B. Taichman Therapy for pulmonary arterial hypertension: the more, the merrier? Ann Intern Med 149 2008 583 585
14. G. Simonneau, I.M. Robbins, M. Beghetti Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 2009 S43 S54
15. O. Sitbon, M. Humbert, X. Jais Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 2005 3105 3111 (Pubitemid 40847788)
16. O. Sitbon, M. Humbert, H. Nunes Long-term intravenous epoprostenol infusion in primary pulmonary hypertension Prognostic factors and survival J Am Coll Cardiol 40 2002 780 788 (Pubitemid 34925627)
17. V.V. McLaughlin, A. Shillington, S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
18. S. Provencher, O. Sitbon, M. Humbert Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension Eur Heart J 27 2006 589 595
19. M. Humbert, O. Sitbon, A. Yaci Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension Eur Respir J 36 2010 549 555
20. R.J. Barst, L.J. Rubin, W.A. Long A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension The Primary Pulmonary Hypertension Study Group N Engl J Med 334 1996 296 302
21. R.N. Channick, G. Simonneau, O. Sitbon Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study Lancet 358 2001 1119 1123 (Pubitemid 32971843)
22. L.J. Rubin, D.B. Badesch, R.J. Barst Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 2002 896 903 (Pubitemid 34984638)
23. O. Sitbon, D.B. Badesch, R.N. Channick Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study Chest 124 2003 247 254 (Pubitemid 36851359)
24. V.V. McLaughlin, O. Sitbon, D.B. Badesch Survival with first-line bosentan in patients with primary pulmonary hypertension Eur Respir J 25 2005 244 249 (Pubitemid 40246523)
25. G. Simonneau, L.J. Rubin, N. Gali Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial Ann Intern Med 149 2008 521 530
26. V.V. McLaughlin, R.J. Oudiz, A. Frost Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension Am J Respir Crit Care Med 174 2006 1257 1263 (Pubitemid 44924827)
27. M. Gomberg-Maitland, V. McLaughlin, M. Gulati Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension Am J Cardiol 96 2005 1334 1336 (Pubitemid 41505420)
28. R.L. Benza, B.K. Rayburn, J.A. Tallaj Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan Chest 134 2008 139 145 (Pubitemid 352008775)
29. M.M. Hoeper, C. Faulenbach, H. Golpon Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension Eur Respir J 24 2004 1007 1010 (Pubitemid 39642293)